Evidence map›Paper›PMID 30013126›Full record

ArticleScientific reports2018

Structural determinants of specificity and regulation of activity in the allosteric loop network of human KLK8/neuropsin.

Mekdes Debela, Viktor Magdolen, Wolfgang Skala, Brigitta Elsässer, Eric L Schneider, Charles S Craik, Martin L Biniossek, Oliver Schilling, Wolfram Bode, Hans Brandstetter and 1 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.7field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 14 citations in OpenAlex.

  1. Drug Discovery Strategies for Kallikrein-Related Peptidases.International journal of molecular sciences · 2025
    Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Coordination chemistry suggests that independently observed benefits of metformin and ZnBiometals : an international journal on the role of metal ions in biology, biochemistry, and medicine · 2024
    Article
  7. Article
  8. Article
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 4 countries.

Mekdes DebelaMax-Planck-Institut für Biochemie, Proteinase Research Group, 82152, Martinsried, Germany.
Viktor MagdolenKlinische Forschergruppe der Frauenklinik, Klinikum rechts der Isar der TU München, 81675, München, Germany.
Wolfgang SkalaDivision of Structural Biology, Department of Biosciences, University of Salzburg, 5020, Salzburg, Austria.ORCID 0000-0002-7350-4045
Brigitta ElsässerDivision of Structural Biology, Department of Biosciences, University of Salzburg, 5020, Salzburg, Austria.
Eric L SchneiderDepartment of Pharmaceutical Chemistry, University of California, San Francisco, CA, 94158, USA.
Charles S CraikDepartment of Pharmaceutical Chemistry, University of California, San Francisco, CA, 94158, USA.
Martin L BiniossekInstitute of Molecular Medicine and Cell Research, University of Freiburg, 79104, Freiburg, Germany.
Oliver SchillingInstitute of Molecular Medicine and Cell Research, University of Freiburg, 79104, Freiburg, Germany.
Wolfram BodeMax-Planck-Institut für Biochemie, Proteinase Research Group, 82152, Martinsried, Germany.
Hans BrandstetterDivision of Structural Biology, Department of Biosciences, University of Salzburg, 5020, Salzburg, Austria.
Peter GoettigDivision of Structural Biology, Department of Biosciences, University of Salzburg, 5020, Salzburg, Austria. peter.goettig@sbg.ac.at.ORCID 0000-0002-2430-1970
University of Salzburg · ATUniversity of California, San Francisco · USUniversity of Freiburg · DEMax Planck Institute of Biochemistry · DETUM Klinikum · DEUniversity of Cambridge · GB

Funding

RESEARCH TRAINING IN CHEMISTRY AND CHEMICAL BIOLOGYT32GM064337 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI CRAIK, CHARLES SCOTT · 2002 to 2021
$7.8M
Renewable antibodies to secreted proteins and single and multi-pass cell surfaceP41CA196276 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI MARKS, JAMES D. · 2014 to 2018
$5.8M
Allosteric Inhibition of a Family of Proteolytic EnzymesR01GM104659 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI CRAIK, CHARLES SCOTT · 2013 to 2016
$1.2M
Austrian Science Fund (FWF Der Wissenschaftsfonds) I631-B11Austrian Science Fund (FWF Der Wissenschaftsfonds) P25003-B21Bundesministerium für Bildung und Forschung (Federal Ministry of Education and Research) Leading Edge Cluster m4Deutsche Forschungsgemeinschaft (German Research Foundation) Graduiertenkolleg 333European Commission (EC) CAMP LSHG-2006-018830NCI NIH HHS P41 CA196276NIGMS NIH HHS R01 GM104659NIGMS NIH HHS T32 GM064337
6 · The paper itself

Abstract

Human KLK8/neuropsin, a kallikrein-related serine peptidase, is mostly expressed in skin and the hippocampus regions of the brain, where it regulates memory formation by synaptic remodeling. Substrate profiles of recombinant KLK8 were analyzed with positional scanning using fluorogenic tetrapeptides and the proteomic PICS approach, which revealed the prime side specificity. Enzyme kinetics with optimized substrates showed stimulation by Ca

Indexed as

Allosteric RegulationAllosteric SiteCalciumCations, DivalentCrystallography, X-RayKallikreinsKineticsLeupeptinsMolecular Docking SimulationMolecular Dynamics SimulationProtein Structure, TertiaryRecombinant ProteinsStructure-Activity RelationshipSubstrate SpecificityZincCalciumCations, DivalentKallikreinsKLK8 protein, humanleupeptinLeupeptinsRecombinant ProteinsZinc

Identifiers

PMID30013126
PMCPMC6048020
OpenAlexW2836277290

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.